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Artificial cells can shed new light on the molecular basis for life and hold potential for new chemical
technologies. Inspired by how nature dynamically regulates its membrane compartments, we aim
to repurpose the endosomal sorting complex required for transport (ESCRT) to generate complex
membrane architectures as suitable scaffolds for artificial cells. Purified ESCRT-III components
perform topological transformations on giant unilamellar vesicles to create complex ‘‘vesicles-
within-a-vesicle’’ architectures resembling the compartmentalization in eukaryotic cells. Thus far,
the proposed mechanisms for this activity are based on how assembly and disassembly of ESCRT-III
on the membrane drives deformation. Here we demonstrate the existence of a negative feedback
mechanism from membrane mechanics that regulates ESCRT-III remodeling activity. Intraluminal
vesicle (ILV) formation removes excess membrane area, increasing tension, which in turn suppresses
downstream ILV formation. This mechanism for in vitro regulation of ESCRT-III activity may also have
important implications for its in vivo functions.
INTRODUCTION
The biological cell is fundamentally a highly complex chemical reactor, where compartmentalization of its
chemical processes is essential for complex functions (Ausländer et al., 2017). Eukaryotic organisms contain
membrane-bound cellular subcompartments, which allow distinct chemical environments to exist within
the cell, such that otherwise incompatible chemistries can be maintained and utilized, e.g., ATP synthesis
in the mitochondria and protein degradation in lysosomes (Satori et al., 2013). The manifold capabilities
of a cell in the synthesis of complex biomolecules and sensing and response to its environment are all
desirable functionalities to emulate within a synthetic system (Chen and Silver, 2012). Therefore chemical
technologies that provide control over the formation of multicompartment membrane architectures are
fundamental to artificial cell engineering (Buddingh’ and van Hest, 2017; Xu et al., 2016).
Althoughmicrofluidic technologies have been developed that allow fixedmulticompartment membrane archi-
tecture to be formed (Deshpande andDekker, 2018; Elani et al., 2018), natural cells can dynamically change their
compartmentalized architectures. To emulate this dynamic nature within an artificial cell system, we take inspi-
ration from biology by repurposing protein complexes in vitro that natively remodel membrane structures
(Beales et al., 2015). The ‘‘vesicles-within-a-vesicle’’ architecture we aspire to recreate in an artificial cell bears
resemblance to a cellular membrane-bound organelle, the multivesicular body (MVB). In eukaryotic cells,
MVBs are formed by the encapsulation of biomolecular cargo into intraluminal vesicles (ILVs) within endosomes
(Hanson and Cashikar, 2012). This membrane remodeling event is performed by the ESCRT (endosomal com-
plex required for transport) machinery (Hurley, 2008). This activity lends itself to the possibility of using ESCRT in
the construction of multicompartment artificial cells in vitro (Marklew et al., 2018).
Human ESCRT drives multiple key membrane-remodeling processes, such as MVB formation, cell division,
exosome formation, HIV budding, and plasma and nuclear envelope membrane repair (Christ et al., 2017;
Hurley, 2015). In yeast, ESCRT is responsible for cargo sorting in the endosomal pathway and also for
nuclear pore complex quality control (Thaller and Lusk, 2018). The ESCRT machinery responsible for trans-
membrane receptor sorting via the endosomal pathway is composed of ESCRT-0, ESCRT-I, and ESCRT-II
protein complexes, which capture ubiquitinated transmembrane cargo at the late endosome membrane
and initiate membrane invagination (Frankel and Audhya, 2018). The central membrane remodeling com-
plex is ESCRT-III, a highly conserved set of proteins in eukaryotes, and the AAA + ATPase Vps4 (Figure 1A)
(Adell et al., 2016; Monroe and Hill, 2016). In Saccharomyces cerevisiae, ESCRT-III consists of a coreiScience 15, 173–184, May 31, 2019 ª 2019 The Authors.
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Figure 1. Experimental Design Rationale
(A) ESCRT-III drives a number of cellular processes that generate new membrane-bound compartments, notably
multivesicular body (MVB) genesis; this process that can be reconstituted in vitro using synthetic vesicles (Wollert et al.,
2009).
(B) ESCRT-III may deform membranes by assembling into ordered supramolecular ‘‘springs’’ (depicted as blue spirals).
Protein stoichiometry and membrane tension were identified as variables that may allow finer control over the size and
number of intraluminal vesicles (ILVs) produced in vitro. Nucleation of Snf7 spiral filaments by Vps20 may provide a means
to control the number of ILVs, whereas Vps24 may act as a terminator or ‘‘cap’’ of Snf7 filament growth, limiting ILV size.
High membrane tension may impede ILV formation by resisting membrane deformation, potentially affecting both the
size and number of ILVs formed.machinery composed of the Vps20, Snf7, Vps24, and Vps2 subunits. ESCRT-III-mediated membrane
budding and scission of vesicles occurs with a unique topology, whereby the membrane is pushed away
from the cytosol (Schöneberg et al., 2017). The initial membrane deformation performed by ESCRT-II re-
cruits ESCRT-III subunits and drives the formation of ESCRT-III filaments on the membrane (Henne et al.,
2013). In vitro studies on flat surface-supported membranes have shown that ESCRT-III forms spirals that
are proposed to behave like springs, storing elastic energy, which deform the membrane upon release
(Chiaruttini et al., 2015). The observation of this spiral structure informs the mechanical rationale for mem-
brane deformation and scission in many of the proposed mechanisms where either a spiral (Chiaruttini and
Roux, 2017), cone (Agudo-Canalejo and Lipowsky, 2018), or dome (Fabrikant et al., 2009; Ró _zycki et al.,
2012) structure made by ESCRT-III stabilizes and subsequently drives scission of the ILV bud neck. This pro-
cess is made possible by the action of the ATPase Vps4, which has been shown to catalyze ESCRT-III activity
by maintaining the dynamics of complex assembly and disassembly (Mierzwa et al., 2017; Adell et al., 2017;
Schöneberg et al., 2018).
ESCRT-II recruits the ESCRT-III subunit Vps20 to form a complex with affinity for regions of membrane cur-
vature (Fyfe et al., 2011). In turn, Vps20 nucleates the formation of Snf7 spirals that are capped at the
growing end by a Vps24-Vps2 complex (Teis et al., 2008). Vps2 recruits the ATPase Vps4 through the inter-
action between itsMIM (MIT-interactingmotif) and theMIT (microtubule-interacting and transport) domain
of Vps4 (Obita et al., 2007; Stuchell-Brereton et al., 2007). ILV formation by ESCRT-II/ESCRT-III can be re-
constituted in vitro with a GUV-based bulk-phase uptake assay. The activity of a minimal ESCRT-III/Vps4
system in artificial vesicle systems was first demonstrated by Wollert et al. (Wollert et al., 2009) where
ILVs were generated in GUV parent vesicles and observed by microscopy. In addition, there are examples
of more minimal sets of ESCRTs inducing ILV formation in vitro, such as Vps20/Snf7 only (Avalos-Padilla
et al., 2018), and some minimal activity with moderate concentrations of Snf7 alone (Marklew et al.,
2018), suggesting further scope for simplification of the system in a technological context.174 iScience 15, 173–184, May 31, 2019
Figure 2. ESCRT-induced ILV Formation Is Characterised by a Bulk Phase Encapsulation Assay
(A) A.1: Confocal microscope image of a cross section (3.1 mm) through a number of GUVs incubated with ESCRT-II, Vps20,
Vps24, Vps2 (10 nM), and Snf7 (50 nM). A number of different ILV sizes are observed in the field of view (1–5). Red,
Rhodamine-PE; green, Alexa Fluor 488-labeled dextran. Scale bar, 10 mm. A.2: ILV morphology, a range of commonly
observed ILV states. (a) Many similarly sized ILVs plus buds, (b) few ILVs of varying dimensions, (c) ‘‘stalled’’ ILV buds with
few or no coincident free-floating ILVs, (d) unusually large ILVs5 mm in diameter. Red, Rhodamine-PE; green, Alexa Fluor
488-labeled dextran. All scale bars, 10 mm.
(B) (i) Schematic of the ILV formation procedure. GUV membranes are labelled by a red Rhodamine lipid probes (1).
Cascade Blue-labeled dextran was added to GUVs in Tris buffer (2), immediately followed by ESCRT-II, Vps20, Vps24,
Vps2 (10 nM), and Snf7 (50 nM) (3). After a 20-min incubation period, Alexa Fluor 488-labeled dextran was added (4),
immediately followed by Vps4 (10 nM) and ATP.MgCl2 (1 mM) (5). Thereby, ILVs containing only Cascade Blue dextran
can be identified as having formed before the addition of Vps4 and ATP, and those that contain both dyes must
have formed after addition. (ii) Confocal image of a GUV containing ILVs formed by active (ATP driven) and passive
(no ATP) processes. Cascade Blue-labeled dextran (blue channel) was added immediately before incubation with
ESCRT-II, Vps20, Vps24, Vps2 (10 nM), and Snf7 (50 nM). Alexa Fluor 488-labeled dextran (green channel) was added
just before the addition of Vps4 (10 nM) and ATP.MgCl2 (1 mM) followed by a further period of incubation. White
arrows indicate passively formed ILVs, and yellow arrows indicate actively formed ILVs. Membranes labeled with
lissamine-Rhodamine-PE (red channel). 403 objective, scale bar, 10 mm.The reconstitution of ESCRT activity in vitro opens the possibility of achieving finer control of ILV formation
in artificial systems. Therefore we initially set out to investigate the relative stoichiometry of ESCRT-III com-
ponents to underpin their influence on the size and number of ILVs that form within individual GUVs (Fig-
ure 1B). Interestingly, our initial experiments reveal wide variation in ILV size and number between different
GUVs within an individual experiment (Figure 2A). Membrane mechanics are considered to be the likely
source of these differences due to variability in tension across a single GUV population. Modulating mem-
brane tension could therefore provide a further means to exert control over ILV formation and will also be
investigated in this study.iScience 15, 173–184, May 31, 2019 175
Here we report on how changing the relative stoichiometry of the ESCRT-III subunits and the mechanical
properties of the membrane regulate the size and number of ILVs formed in a GUV-based bulk-phase up-
take assay (Figure 1B). These findings reveal a mechanism that regulates ESCRT activity in vitro and provide
further insight into how they may function in vivo.
RESULTS
‘‘Passive’’ and ‘‘Active’’ Membrane Budding and Scission by ESCRT
ESCRT components were overexpressed and purified from appropriate plasmids (see Transparent Methods
and Figure S1). We have quantified ESCRT activity using the bulk-phase uptake assay as described by Wollert
and Hurley (Wollert et al., 2009), introducing a systematic variation in the ratio of key ESCRT-III in the reaction. In
this assay,GUVswith an ‘‘endosome-like’’ lipid composition (Wollert et al., 2009) are incubatedwith the ESCRT-II
complex (Vps22, Vps36, Vps25), and the core ESCRT-III subunits Vps20, Vps24, Vps2, and Snf7. Before the addi-
tion of proteins, amembrane-impermeable, fluorescent dextran (Mr 5 kDa, Cascade Blue labeled) is added to
the GUV suspension to establish whether newly formed ILVs have encapsulated bulk phase (Figure 2A).
Confocal microscopy (Figure 2B) is used to assess the number of ILVs, and the observed diameter of each
ILV is recorded (observed diameter may not be the true maximum diameter of the ILV). Only ILVs visibly con-
taining dextran fluorescence are counted, as this confirms their formation following addition of the proteins.
The number of ILVs and the volume of the GUV lumens in the image is then used to calculate the number of
ILVs per unit volume, the unit volume being taken as that of an average 20-mm-diameter GUV, hence ‘‘ILVs
per GUV volume equivalent.’’ Controls containing only osmotically balanced buffer and fluorescent dextran
give a minimal background level of ILVs formed within the experimental period (see ‘‘no protein control’’ in
figure legends). The process of ILV formation observed in the absence of Vps4 andATP is referred to as ‘‘passive
– ESCRT only,’’ or simply ‘‘passive’’ because it identifies budding events that are independent of energy input
fromATP hydrolysis, dependent only onESCRT-III. In the context of in vivoESCRT activity, this process would be
considered to be off-pathway as recent evidence supports the requirement of the ATPase activity of Vps4 for
efficient membrane deformation and scission (Adell et al., 2014, 2017; Mierzwa et al., 2017). A second fluores-
cent dextran (Mr  10 kDa, Alexa Fluor 488 labeled) can be added to this GUV population, followed by 20-min
incubation with Vps4 and ATP.MgCl2. Newly formed ILVs in these conditions will contain blue and green fluo-
rescence. The process of ILV formation driven byATP hydrolysis by Vps4 is referred to as ‘‘active+Vps4/ATP,’’
or simply ‘‘active.’’ Both passive and active formation of ILVs, induced by the action of ESCRTs, is observed in
GUVs (Figure 2B (ii)).
ILV Formation Efficiency Reaches a Maximum for a Specific Molar Ratio of Snf7
Snf7 oligomerization is central to ESCRT-III activity, with more Snf7 units present in the active complex than
other ESCRTs (Wollert and Hurley, 2010). The relationship between ESCRT-III subunit stoichiometry and
activity has been studied in vivo (Adell et al., 2017), whereas this is currently not well understood in vitro.
Bulk-phase encapsulation assays are performed at a range of Snf7 concentrations (5–250 nM) and maintain
a fixed concentration (10 nM) of each of the remaining ESCRT-II and ESCRT-III components (Figure 3). For
both passive and active processes, 50 nM Snf7 provides the greatest activity in terms of number of ILVs
observed, with no improvement at 250 nM. Interestingly, this is comparable to Snf7 being present at
approximately up to five times the concentration of other ESCRT-III components in yeast (Adell et al.,
2017; Wollert and Hurley, 2010).
A similar number of ILVs form during the passive and active processes, which may indicate ‘‘recycling’’ of the
membrane-bound ESCRT components once and their reassembly into a similar number of active complexes.
However, other explanationsareplausible, and thismaybecomplicatedby changesand variability inGUVmem-
brane tension in the second ‘‘active’’ round of ILV formation. ILV size is also found to be generally consistent
across the full concentration range, with the only significant differences being found between active and passive
processes at the 10 nM and 50 nM Snf7 concentrations, where ATP-fueled ‘‘active’’ formation favors slightly
smaller ILVs, on average. Below 10 nMand above 50 nMSnf7may be too little or toomuch protein, respectively,
with respect to other ESCRT-III components to produce fully competent complexes.
The role of Vps4 ATPase activity in the active process is confirmed by the control experiments in Figure 3 (ii).
Omission of Vps4 or replacement of ATP with a non-hydrolyzable ATP analog (adenylyl-imidodiphosphate)
significantly supresses the active formation process. Nonetheless, a few Alexa Fluor 488-labeled dextran-
containing ILVs are observed in each case. This low background rate of encapsulation may be the result of176 iScience 15, 173–184, May 31, 2019
Figure 3. Snf7 Stoichiometry Bulk-Phase Encapsulation Assay; ILV Counting and Characterization by Confocal
Microscopy
ILVs containing fluorescent dye in their lumens after the addition of ESCRT proteins. (i) Number: number of ILVs per GUV
volume equivalent; the number of ILVs observed per volume of a 20-mm-diameter sphere. Size: mean diameter of the
observed ILVs. Blue: ‘‘passive’’ formation. ILVs containing Cascade Blue-dextran, after simultaneous addition of ESCRT-II,
Vps20, Vps24, and Vps2 (10 nM) and Snf7 at the concentration stated on the x axis, but before the addition of 10 nM Vps4
and 1 mM ATP.MgCl2. Green, ‘‘active’’ formation. ILVs containing Alexa Fluor 488-dextran observed after the addition of
10 nM Vps4 and 1 mM ATP.MgCl2. Corresponding size histograms for each data point are presented in Figure S4. (ii)
ATPase activity controls: number of ‘‘actively’’ formed ILVs (containing both blue and green dyes) per GUV volume
equivalent. ‘‘No protein,’’ GUVs with no addition of protein incubated with both dextran dyes for the same time as the
protein-containing experiments; ‘‘no Vps4,’’ all proteins added (50 nM Snf7, 10 nM others) + 1 mM ATP.MgCl2 with Vps4
omitted; ‘‘NH-ATP,’’ all proteins added (50 nM Snf7, 10 nM others) + 1 mM MgCl2 and the non-hydrolyzable ATP (‘‘NH-
ATP’’) analog adenylyl-imidodiphosphate; ‘‘ATP,’’ all proteins (50 nM Snf7, 10 nM others) + 1 mM ATP.MgCl2. Osmotically
relaxed vesicles were used in all experiments. Data are represented as themean valueG standard error of the mean. Each
data point is averaged from n = 3 independent experiments, each containing 100+ independent GUVs. Significance
testing: one-way ANOVA with Bonferroni test, one-tailed, *p < 0.05, **p < 0.01, ***p < 0.001. No ESCRT control
background rate = 0.067 ILVs per unit volume (standard error: 0.016).mechanical disturbance of the sample solution during the addition of the second round of proteins/ATP.
Vps4 itself may possess some innate activity in the absence of ATP, which may account for the slightly
greater number of ‘‘green’’ ILVs found in that case, but the difference between the ‘‘NH-ATP’’ and ‘‘no
Vps4’’ controls is not found to be significant. Figure 3 (ii). ‘‘ATP’’ contains the full set of proteins plus
ATP.MgCl2, at the same concentrations as Figure 3 (i) ‘‘50 nM,’’ but a higher number of ILVs per GUV volume
equivalent is observed in these experiments. This variability is ascribed to variation in protein quality be-
tween expressed batches: all data presented on a single plot are obtained with the same batch of protein.
This means that there are small differences between some of the absolute values and associated errors of
ILVs formed under nominally identical conditions within the different figures because these were indepen-
dent experiments performed with different protein batches.Membrane Tension Is the Dominant Factor in ILV Formation Efficiency and Size: Protein
Stoichiometry Effects Are Minimal
Vps20 bridges ESCRT-III to ESCRT-II and is involved in the nucleation of Snf7 oligomers onto endosomal
membranes in vivo (Fyfe et al., 2011; Henne et al., 2012). Vps20 possesses an N-terminal myristoylation
that facilitates binding to membranes in general (Im et al., 2009); the ESCRT-II complex activates Vps20
by a mechanism including binding to the subunit Vps25 and generating initial invagination of the mem-
brane (Boura et al., 2012). Activation of Vps20 leads to the recruitment and assembly of Snf7 and otheriScience 15, 173–184, May 31, 2019 177
Figure 4. Vps20 Stoichiometry Bulk-Phase Encapsulation Assay; ILV Counting and Characterization by Confocal
Microscopy
ILVs containing fluorescent dye in their lumens after the addition of ESCRT proteins. Number: number of ILVs per
GUV volume equivalent. Size: mean diameter of the observed ILVs. Blue, high-membrane-tension GUVs; red, low-
membrane-tension GUVs. Passive: ILVs observed after simultaneous addition of ESCRT-II, Vps24, and Vps2 (10 nM),
Snf7 (50 nM), and Vps20 at the concentration stated on x axis, but before the addition of 10 nM Vps4 and 1 mM
ATP.MgCl2. Active: after the addition of 10 nM Vps4 and 1 mM ATP.MgCl2. Data are represented as the mean
value G standard error of the mean. Each data point is averaged from n = 3 independent experiments, each
containing 100+ independent GUVs. Significance testing: one-way ANOVA with Bonferroni test, one-tailed, *p < 0.05,
**p < 0.01. No ESCRT control background rate for low tension GUVs = 0.067 ILVs per unit volume (standard error:
0.016), for high tension GUVs = 0.054 ILVs per unit volume (standard error: 0.017). Corresponding size histograms for
each data point are presented in Figure S5.downstream ESCRT-III proteins (Fyfe et al., 2011; Im et al., 2009). Nucleation is a critical step in the forma-
tion of ILVs, therefore Vps20 stoichiometry was examined for its influence on ILV size and number. Varying
the Vps20 concentration relative to that of other ESCRT-III components should provide different numbers
of potential nucleation sites for ESCRT-III assembly. A higher number of nucleation sites should result in a
similarly higher number of ILVs, provided that there are sufficient other ESCRT-III components to form func-
tional assemblies at each of these sites. The ‘‘dilution’’ of the available ESCRT-III components across a
larger number of nucleation sites may also result in smaller Snf7 assemblies, which may give rise to smaller
ILVs, if there is a relationship between the size of the complex and the resulting ILV. Furthermore, these
experiments are performed with both high- and low-membrane-tension GUVs, where low-tension GUVs
are subjected to an osmotic relaxation protocol, to assess the influence of membrane mechanics.
Across a 50-fold variation in concentration, the relative stoichiometry of Vps20 to other ESCRT subunits
does not appear to have a significant effect on the number of ILVs observed (Figure 4 ‘‘number’’), whereas
a reduction in membrane tension results in 3–4 times the number of ILVs formed per unit volume for both
active and passive activities. Neither Vps20 stoichiometry nor membrane tension have a significant effect
on ILV size (Figure 4 ‘‘size’’).
In a recent model of ESCRT-III assembly (Chiaruttini et al., 2015; Mierzwa et al., 2017; Saksena et al., 2009),
Vps24 and Vps2 bind to the growing end of the Snf7 filament providing a limiting signal to filament growth
by terminating Snf7 spiral elongation. Vps2 recruits the ATPase Vps4 to the ESCRT-III assembly to recycle178 iScience 15, 173–184, May 31, 2019
Figure 5. Vps24 Stoichiometry Bulk-Phase Encapsulation Assay; ILV Counting and Characterization by Confocal
Microscopy
ILVs containing fluorescent dye in their lumens after the addition of ESCRT proteins. Number: number of ILVs per GUV
volume equivalent. Size: mean diameter of the observed ILVs. Blue, high-membrane-tension GUVs, red, low-membrane-
tension GUVs. Passive: ILVs observed after simultaneous addition of ESCRT-II, Vps20, and Vps2 (10 nM), Snf7 (50 nM), and
Vps24 at the concentration stated on x axis, but before the addition of 10 nM Vps4 and 1 mM ATP.MgCl2. Active: after the
addition of 10 nM Vps4 and 1 mMATP.MgCl2. Data are represented as themean valueG standard error of the mean. Each
data point is averaged from n = 3 independent experiments, each containing 100+ independent GUVs. Significance
testing: one-way ANOVA with Bonferroni test, one-tailed, *p < 0.05, **p < 0.01, ***p < 0.001. No ESCRT control
background rate for low-tension GUVs = 0.067 ILVs per unit volume (standard error: 0.016), for high-tension GUVs = 0.054
ILVs per unit volume (standard error: 0.017). Corresponding size histograms for each data point are presented in
Figure S6.the proteins and allow for multiple rounds of ILV formation. However, competingmodels have also recently
suggested the formation of mixed Snf7, Vps2, and Vps24 filaments where each protein has a different
preferred curvature in the spiral assembly (Chiaruttini and Roux, 2017). In this experiment, we test how vary-
ing Vps24 stoichiometry influences the efficiency of ILV formation, which may occur either by premature
termination of ESCRT-III filament growth or alternatively, by modulating the stored elastic energy in spiral
ESCRT complexes.
Overall, we see a weak dependence of Vps24 stoichiometry on the efficiency of ILV formation in a similar fashion
towhatwas observed for Vps20 (Figure 5), where the effects ofmembrane tension dominate the actions induced
by stoichiometric changes of Vps24 with a 3- to 5-fold increase in ILV number in the low-tension regime. How-
ever, at the lowest Vps24 concentration (5 nM), there appears to be an inhibitory effect on ILV number in the low-
tension GUV population, but in high-tension samples, no Vps24 concentration effect on number is observed.
GUVs in the low-tension regime also display an effect of Vps24 stoichiometry on the size of ILV produced,
with the lowest Vps24 concentration producing significantly larger mean ILV diameter for both active and pas-
sive formation, suggestive that increased capping of the complex by Vps24 favors smaller ILV sizes. Further-
more, we see a significant increase in ILV size in the low-tension regime in these experiments, indicating that
lowermechanical resistance tomembranedeformation facilitatesmoremembrane, on average, being removed
from the parent GUV in an individual ILV formation event.
Taken together, our data show that membrane tension plays a major role in regulating ESCRT-driven ILV
formation.iScience 15, 173–184, May 31, 2019 179
Membrane Tension Negatively Regulates ILV Formation by ESCRT-III
The deformation of a membrane during ESCRT-induced ILV budding would encounter greater mechanical
resistance on higher tension membranes. The energetic input to achieve this may be derived from the as-
sembly of ESCRT-III components, primarily Snf7 filaments, which are directly implicated in driving mem-
brane budding. Although the role of Vps4, a mechanoenzyme, has been suggested to be in the scission
of ILV buds from their parent membrane through the disassembly of stabilizing Snf7 filaments, some pub-
lished results have suggested that ESCRT complexes only exert measurable forces on membranes during
ATP-driven Vps4 activity (Schöneberg et al., 2018).
Our data reveal a strong, significant dependence of the efficiency of ILV formation on membrane tension,
implying that typical membrane tensions in GUVs are sufficient to compete with the energetic driving force
of membrane deformation exerted by the ESCRT complex. Therefore regardless of the mechanism or
magnitude of the force exerted, there must exist a maximum membrane tension that is able to undergo
ESCRT-induced ILV budding. A relationship between ILV size and membrane tension is also plausible as
the magnitude of membrane deformation that can be achieved during budding may be modulated by ten-
sion. Any such effects resulting from resistance to membrane deformation will necessarily be concurrent
with any effects resulting from transient membrane curvature. As assemblies of ESCRT-II and Vps20 are
known to have an increased affinity for regions of membrane curvature (Fyfe et al., 2011), the transient cur-
vature changes from membrane undulations that are more pronounced in low-tension membranes may
also enhance the affinity of ESCRT-II/Vps20 complexes for the membrane.
Interestingly, we find that the suppression of ILV formation is of a similar extent in both the passive and active
processes. This implies that the inhibitory mechanism is not significantly dependent on Vps4 and ATP.
Therefore we hypothesize that either the complex exerts a similar magnitude of deformation force on the
membrane in both the active and passive processes or the increased recruitment of ESCRTs to the mem-
brane due to enhanced undulatory curvature at low membrane tension is the dominant factor. As a recent
report shows measurable membrane deformation forces only occur due to Vps4 activity (Schöneberg et al.,
2018), this lends favor to the latter interpretation. Interestingly, simulations have previously reported anal-
ogous tension-dependent assembly of N-BAR domains on membranes (Simunovic and Voth, 2015).
Flicker spectroscopy experiments are used to quantify the distribution of membrane tensions (s) in
GUV populations in our low- and high-tension regimes, before and after incubation with ESCRT proteins
(Figures 4, S2, and S3.).
GUVs are found to have high membrane tension following initial electroformation. Addition of the ESCRT
complex resulted in a narrowing of the distribution of membrane tensions toward the high-tension end
of the initial distribution (Figure S2). This implies that the lower-tension vesicles within the initial popu-
lation have increased their tension due to their interaction with ESCRTs. This is likely due to ILVs forming
within the less tense vesicles of the high-tension population and a significant number of GUVs where no
ILVs have formed are observed in these samples, suggesting that their tension might be too high for the
ESCRT complex to act upon them. Some GUVs in these samples are too tense to be quantified by the full
flicker analysis as the data for higher q modes became noisy owing to their small amplitude. Therefore
the mean square amplitudes of the longest wavelength undulatory mode (n = 3) are analyzed as a proxy
for membrane tension where smaller mean square amplitudes correspond to a higher membrane tension
(Amjad et al., 2017).
The mechanical coupling between membrane tension and ESCRT function is most evident in the low-ten-
sion regime. As expected, the osmotic relaxation procedure reduces the mean membrane tension by
about an order of magnitude and also narrows the range of tension values across the population (Figure 6
‘‘relaxed GUVs’’). As discussed above, the error of the full analysis of flicker spectrum increases at higher
tension, therefore we present both the absolute tension measurement and the mean-square amplitude
of the third mode in Figure 6 to demonstrate that both analysis methods demonstrate the same data
trends. Similarly, due to increasing tension after protein addition, bending modulus (k) values could only
be reliably obtained for osmotically relaxed GUVs before the addition of the ESCRT proteins. Relaxed
GUVs were found on average to have k = 24.5 kBT, which agrees with those typically reported for 1-palmi-
toyl-2-oleoyl-glycero-3-phosphocholine (POPC) and cholesterol membranes (Dimova, 2014; Henriksen
et al., 2006).180 iScience 15, 173–184, May 31, 2019
Figure 6. ESCRT Activity Increases Membrane Tension
(i) The distribution of membrane tension s in GUV samples. (ii) Distributions for the values of the amplitude of the third
vibrational mode for the same GUVs. ‘‘Tense’’ GUVs were those that were not exposed to an osmotic gradient. The
membrane tension of osmotically ‘‘relaxed’’ GUVs was measured before (pre-protein) and after (post-protein) the
addition of the ESCRT proteins to assess the effect of ILV formation on membrane tension. Box descriptions: -,
mean values; line termini correspond to the minimum and maximum observed values; the upper and lower bounds of the
boxes correspond to the 75th and 25th percentile values, respectively; and the inner line corresponds to the 50th
percentile. n = 10. See also Figures S2 and S3.ESCRT activity increases membrane tension. Further flicker spectra are obtained after incubation with
ESCRT proteins, using our standard procedure (50 nM Snf7; 10 nM ESCRT-II, Vps20, Vps24, Vps2, and
Vps4; 1 mMATP.MgCl2, 20-min incubation) (Figure 6. ‘‘relaxed GUVs + ESCRT-III’’). The mean tension after
ILV formation increases to an intermediate value between the ‘‘tense’’ GUVs and those that have
been osmotically relaxed ‘‘pre-protein.’’ This increase in membrane tension will act to make further ILV for-
mation more difficult, providing a mechanism of negative feedback to self-regulate ESCRT activity.
Notably, the ‘‘post-protein’’ tension range does not reach the highest tension values observed in the initial
electroformed GUV population, suggesting that in these cases, ILV formation is not limited by the mem-
brane mechanics and further ILV formation is likely possible upon addition of more ESCRT-III or further
active recycling of the existing components.
DISCUSSION
Here we have shown that ESCRT-III activity is regulated by the tension of the membrane substrate, using
an in vitro model membrane system. Our work recapitulates ESCRT-mediated membrane budding and
scission in the GUV system and shows that membrane tension significantly dominates over any attempt
to control ILV formation by varying the ratio of the ESCRT-III assembly reaction. Increased membrane ten-
sion through removal of excess membrane surface area provides a negative feedback mechanism that
eventually suppresses membrane remodeling by ESCRT-III.
Based on a model wherein individual ESCRT constituents promote nucleation (Vps20), growth (Snf7), and
termination (Vps24) of the ESCRT filaments, we hypothesized that variation of relative ratio between sub-
units may affect the efficiency of ILV formation and ILV size. Nonetheless, we observed minimal effects on
ILV formation efficiency and size when varying Vps20 and Vps24 concentration across a 50-fold concentra-
tion range. Therefore, ILV formation under these conditions is weakly dependent on Vps20 and Vps24. This
suggests that either membrane mechanics strongly dominates the effects of nucleation and termination in
our experimental regime or there is a narrow range of stoichiometric composition where functional ESCRT
complexes form, giving rise to a weak dependence on the concentration of a single component. We
consider the latter scenario to be most likely given that ILV formation in relaxed vesicles is not limited
by membrane mechanics at the typical protein concentrations used (Figure 6).
Mechanistic models of ESCRT activity revolve around the formation of circular or spiral structures on mem-
branes that drive membrane invagination (Chiaruttini et al., 2015), constricting and stabilizing ILV bud
necks (Adell et al., 2014) before scission by disassembly of the oligomer (Hurley and Hanson, 2010). None-
theless, membrane curvature drives the recruitment of specific ESCRT subunits (Castro-Gomes et al., 2014)
and membrane undulations, amplified at low tension, have been implicated in promoting self-assembly of
other curvature-generating proteins at the membrane (Simunovic and Voth, 2015). Hence a more complete
model for ESCRT-mediated remodeling activity includes the membrane as an active participant. Here, weiScience 15, 173–184, May 31, 2019 181
have elucidated a regulatory role for membrane mechanics in preventing runaway overactivity of the
ESCRT complex via a negative feedback mechanism.
Minimal model systems provide clues to the biological mechanisms and interactions of the reconstituted
components, allowing hypotheses to be generated about the more complex biological scenario. ESCRTs
perform a wide variety of membrane remodeling functions within the cell (Hurley, 2015) with some of these
responding directly to changes in membrane tension, such as membrane abscission during cytokinesis,
whereby relaxation of membrane tension promotes recruitment of ESCRT-III to the intercellular bridge
(Lafaurie-Janvore et al., 2013). In the endocytic pathway, fusion of endosomes may provide excess mem-
brane that lowers tension and could therefore facilitate generation of internal vesicles by ESCRT-III, sug-
gestive of a homeostatic relationship between endosomal fusion and formation of vesicles within the
MVB (Skjeldal et al., 2012). ESCRTs also play an important role in plasma and nuclear envelope membrane
repair, where a loss in tension caused by membrane impairment could contribute to the rapid recruitment
of the complex to the site of damage. Notably, the plasma membrane structures known as caveolae, and
their associated proteins, act as a store of excess membrane area that provides a stress-responsive buffer
of membrane tension, and their involvement in numerous signaling pathways demonstrates the sensitivity
of cellular processes to changes in membrane tension (Parton and del Pozo, 2013).
Membrane tension could provide a general means of regulating ESCRT activity. Plasmamembrane tension
has been reported in the low tens of mN m1 range (Sens and Plastino, 2015), which is above the range of
values observed in our GUV membranes. This may suggest that ESCRT remodeling activity is generally in-
hibited until local events at the membrane lower tension and promote ESCRT reactions. Cellular mem-
branes lacking cytoskeleton support, such as blebs, have tensions typically in the mN m1 range (Sens
and Plastino, 2015), matching the higher end of our measured values. Accordingly, our data show a signif-
icant increase in efficiency of ESCRT activity (as measured by efficiency of ILV formation) associated with a
change in mean tension from 4.8 mNm1 to 0.6 mNm1. These represent physiologically relevant values of
membrane tensions supporting the inference of our model for ESCRT activity regulation by membraneme-
chanics not only in vitro but also in vivo.
Our primary interest is to develop the ESCRT proteins as a means of directing compartmentalization in arti-
ficial cell systems, ultimately to enable dynamic control over their compartmentalized structures. Although
the fundamental ILV-forming activity of ESCRT-III in GUVs is well established, our intention is to determine
means of exerting finer control over compartment parameters, such as size, number, and cargo encapsu-
lation. Membrane tension provides a promising control parameter to regulate ILV formation in GUVs and is
suggestive of strategies that would allow multiple rounds of ILV formation to provide numerous distinct
artificial organelles within GUV artificial cells.Limitations of the Study
Our study clearly demonstrates that membrane tension acts to regulate ILV formation by ESCRT in giant
vesicle artificial cells. This tension control is most evident in the number of ILV compartments that are
formed. We found that there is little control over the size of the ILV compartments, hence alternative ap-
proaches are required if compartment size would be an important parameter to regulate. Stoichiometry
of ESCRT components appears to have a weak effect on ILV formation efficiency in our experimental con-
ditions; however, this does not completely rule out stoichiometric control as this may exist in a different
concentration regime. The parameter space for varying the concentrations and relative stoichiometries
of ESCRT components is extremely broad and unfeasible to fully cover in a single study. We propose
that the regulation of ESCRT activity by membrane mechanics observed in vitro will have relevance to un-
derstanding of ESCRT function in vivo. Naturally, further studies designed to elucidate this phenomenon in
the complex cellular environment are required to confirm these predictions.METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.DATA AND SOFTWARE AVAILABILITY
The data files supporting this manuscript are available online in the Research Data Leeds repository
at https://doi.org/10.5518/549.182 iScience 15, 173–184, May 31, 2019
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Supplementary Figure S1. Related to Figure 1. A: comassie-stained 10% SDS-
PAGE of purified ESCRT-II and ESCRT-III proteins. B: size-exclusion 
chromatograms of Vps20, Snf7, Vps24, and Vps2. Purified proteins were run on a 
Superdex 75 (10/300 GL) column (GE Healthcare) at 0.8 ml min-1. The absence of 
large oligomeric species was judged by the presence of a single peak corresponding 
to a low molecular weight. 
 
Supplementary Figure S2. Related to Figure 6. A: The distribution of values for the 
mean squared amplitude of the third undulatory mode <│u(q3)│2> of tense GUVs 
(that have not been subjected to an osmotic gradient), before and after the addition 
of protein. Box descriptions: ■ – mean values, line termini correspond to the 
minimum and maximum observed values, the upper and lower bounds of the boxes 
correspond to the 75th and 25th percentile values respectively and the inner line, the 
50th percentile. Lower values of <│u(q3)│2> correspond higher to membrane tension 
values (σ). ‘Tense GUVs’: GUVs before addition of ESCRT proteins. ‘Tense GUVs 
+ ESCRT-III’: GUVs after the addition of ESCRT-II, Vps20, Vps24, and Vps2 (10 
nM), Snf7 (50 nM) and Vps4 (10 nM) and ATP.MgCl2 (1 µM). Note that the y-axis is 
inverted so that higher tension data appear near the top of the graph. Box 
descriptions: ■ – mean values, line termini correspond to the minimum and 
maximum observed values, the upper and lower bounds of the boxes correspond to 
the 75th and 25th percentile values respectively and the inner line, the 50th percentile. 
n=10.  B: An example flicker spectrum for membrane undulation tracking, resulting 
power spectrum and fitting to Equation 1. Where <│u(qx)│2> is the mean squared 
amplitude of a given vibrational mode.The datapoint corresponding to the third 
vibrational mode, used to estimate membrane tension for very tense membranes, is 
highlighted with a red circle. 
 
 
Supplementary Figure S3. Related to Figure 6. Example flicker spectra for key 
conditions in main paper Figure 6. (i): Tense GUVs, (ii): Osmotically relaxed GUVs, 
(iii): Osmotically relaxed GUV after ESCRT-induced ILV formation. Poor fitting to the 
model is observed for the exemplar highly tense GUV spectrum given in S3(i), 
necessitating examination of amplitude of the third undulatory mode (see Figure 6(ii) 
and S2) 
 
Supplementary Figure S4. Related to Figure 3. Histograms of observed ILV 
diameters as a percentage of the total number of ILVs at different Snf7 
concentrations with 10 nM each of ESCRT-II, Vps20, Vps24, Vps2 (plus 10 nM Vps4 
and 1 µM ATP.MgCl2 for active formation) (see Figure 3). Blue bars = passive 
formation, green bars= active formation. Error bars are +/- the standard error of the 
mean.  
 
Supplementary Figure S5. Related to Figure 4. (i) Histograms of observed ILV 
diameters as a percentage of the total number of ILVs at different Vps20 
concentrations for passive ILV formation conditions (see Figure 4): 10 nM each of 
ESCRT-II, Vps24, Vps2, Vps2. Blue bars: high membrane tension GUVs, Red 
bars: low membrane tension GUVs. (ii): Histograms of observed ILV diameters as a 
percentage of the total number of ILVs at different Vps20 concentrations under 
active conditions: 10 nM each of ESCRT-II, Vps24, Vps2, Vps2 + 10 nM Vps4 and 1 
µM ATP.MgCl2 (see Figure 4). Blue bars: high membrane tension GUVs, Red 






Supplementary Figure S6. Related to Figure 5. (i) Histograms of observed ILV 
diameters as a percentage of the total number of ILVs at different Vps24 
concentrations for passive ILV formation conditions (see Figure 5): 10 nM each of 
ESCRT-II, Vps20, Vps2, Vps2. Blue bars: high membrane tension GUVs, Red 
bars: low membrane tension GUVs. (ii): Histograms of observed ILV diameters as a 
percentage of the total number of ILVs at different Vps24 concentrations under 
active conditions: 10 nM each of ESCRT-II, Vps20, Vps2, Vps2 + 10 nM Vps4 and 1 
µM ATP.MgCl2 (see Figure 5). Blue bars: high membrane tension GUVs, Red 







Protein over-expression and purification 
The plasmids for overexpression of Saccharomyces cerevisiae ESCRT-II (Vps22, Vps25, 
Vps36) and ESCRT-III subunits Vps20, Snf7, Vps2 are a gift from James Hurley (addgene 
plasmids #17633, #21490, #21492, #21494)(Wollert et al., 2009; Wollert and Hurley, 2010). 
The yeast Vps24 gene is subcloned into a pRSET(A) expression vector, containing a His6-tag 
and Enterokinase protease cleavage site. All constructs are transformed into JM109 (DE3). 
All proteins are expressed in autoinduction media, including trace elements (Formedium). 2 
L of culture are grown in the presence of ampicillin (final concentration of 100 mg/L) for 3 hr 
at 37 °C and then the temperature is reduced to 25 °C overnight. Cells are broken with a cell 
disrupter (Constant systems), cooled to 4 °C and the supernatant is separated from the 
debris by centrifugation at 30,000 x g.  ESCRT-II is purified as a complex (Vps22 contains a 
His6 tag) using a HisPrep FF 16/10 (GE Healthcare) in PBS, with an elution gradient of 
imidazole up to 1 M. The eluted complex is buffer exchanged into PBS, flash frozen and 
stored −80° C until use. ESCRT-III proteins (Vps20, Snf7, Vps2) are affinity purified using MBP 
resin (GE Healthcare) and eluted with 10 mM maltose. Vps24 is denatured in 5 M urea and 
applied to IMAC Sepharose resin charged with Ni2+ (GE Healthcare) and after washing is 
eluted over a 0 - 500 mM imidazole gradient. Elution fractions (Vps20, Snf7, Vps2) are 
cleaved using TEV protease (pET28-MBP-TEV is a gift from Zita Balklava & Thomas Wassmer; 
addgene plasmid # 69929) (Currinn et al., 2016). TEV protease is removed with a second 
round of Ni2+ affinity chromatography. Pooled fractions are finally purified by size exclusion 
chromatography (SEC). The monomeric state of all proteins is verified using analytical SEC 
(Superdex 75 10/30 column; GE Healthcare) (Figure S1 (i)). Purified proteins are maintained 
at concentrations not higher than 8 μM to avoid aggregation and aliquoted in small volumes 
(~50 µL) for one-time use only to avoid damaging from freeze-thawing. Aliquots are 
immediately flash frozen in liquid nitrogen and stored at −80° C until use. Full-length yeast 
Vps4 (a gift from James Hurley; addgene plasmid #21495) is purified from E. coli as a 
glutathione S-transferase fusion protein following the method in Wollert and Hurley 2009 
(Wollert et al., 2009). The purified protein is concentrated to 20 μM, tested for ATPase 
activity and stored at −80 °C. Proteins are defrosted on ice prior to use. 
 
Electroformation of Giant Unilamellar Vesicles (GUVs)  
Preparation of GUVs is performed using the electroformation method. A solution of lipids in 
chloroform (15 µL, 0.7 mM; (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC, 
61.9 mol%), 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS, 10 mol%), 
cholesterol (25 mol%), 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3'-phosphate) 
(PI(3)P, 3 mol%), and lissamine-rhodamine-PE (0.1 mol%), all purchased from Avanti Polar 
Lipids Inc. Alabaster, Al. USA.) is applied as a thin layer over two Indium-tin oxide (ITO) glass 
slides (8-12 Ω/sq, Sigma-Aldrich) and dried under a stream of nitrogen gas. The slides are 
assembled into an electroformation chamber using a silicone rubber gasket to create a 
chamber between the opposing conductive surfaces, with strips of copper tape between the 
gasket and each conductive surface to serve as electrical contacts. The chamber is filled with 
sucrose solution (600 mM) and sealed with a silicone rubber plug. The chamber is placed in 
an oven at 60 °C and using a function generator, an AC voltage was applied to the system (3 
V peak to peak, 10 Hz, sinusoidal waveform) for two hours, followed by gradual reduction in 
the frequency over approximately 10 minutes to facilitate the closure of nascent GUVs from 
the surface. The chamber is then allowed to cool to room temperature before the GUV 
suspension is harvested. 
 
If desired, osmotic relaxation of membrane tension is achieved by overnight incubation at 4 
°C of the resulting GUV suspension in Tris buffer (50 mM Tris, pH 7.4) adjusted to 10 mOsM 
higher than the sucrose electroformation solution (1:4, vol:vol Tris:GUV suspension) to 
facilitate the osmotic transport of water from the GUV lumens. Osmolarity is measured 
using an Advanced Instruments 3320 osmometer and adjusted by addition of NaCl. 
  
Confocal microscopy - ILV counting 
Confocal microscopy is performed on a Zeiss LSM 880 inverted system, using a Plan-
Apochromat 40x/1.4 Oil DIC M27 objective lens, NA = 1.4. 8-well glass bottomed imaging 
chambers (ibidi GmbH) are prepared by passivation of the interior glass surface by 
incubation overnight in 5 % Bovine serum albumin (BSA) solution, followed by copious 
rinsing with MilliQ water. A GUV suspension is diluted 1:4 with osmotically balanced Tris 
buffer, unless previously diluted with 10 % hyperosmotic Tris buffer as described previously 
for membrane relaxation. To ensure efficient mixing for each experiment, solutions are 
combined in an Eppendorf tube, followed by gentle agitation of the tube and transfer of the 
solution to the imaging chambers. Proteins are thawed over ice, before being added to the 
tubes such as to give final concentration of 10 nM ESCRT-II, Vps20, Vps24 and Vps2, and 50 
nM Snf7, unless otherwise stated. Aliquots of proteins are used only once and never re-
frozen and thawed again. Fluorescently labelled dextran (Mr ~ 5,000 Da, Cascade blue 
labelled) is then added, followed by 200 μL of GUV suspension. Imaging is then performed 
after 20 minutes of incubation. Once imaging is complete, a second fluorescent dextran (Mr 
~ 10,000 Da, AlexaFluor 488 labelled) is added to each sample, followed by 10 nM Vps4 and 
1 μM ATP.MgCl2 and further imaging is performed after a 20 minute incubation period. For 
the ILV counting experiments, a tile scanning technique with a 3.1 μm section thickness is 
employed to capture a cross sectional volume through a large number of GUVs. Only ILVs 
visibly containing encapsulated dextran dye are counted, indicating that they have formed 
after the addition of the proteins. The apparent diameters of observed ILVs was measured 
manually during counting and binned into categories of ≤0.5 μm, 1 μm, 2 μm, 3 μm etc. The 
counts associated with each of these categories were used to produce ILV size histograms 




GUV membrane tension is quantified by flicker spectroscopy (Alex Rautu et al., 2017; 
Bassereau et al., 2014; Yoon et al., 2010). This technique analyses the power spectrum of 
membrane undulations (mean square undulation amplitude 〈|𝑢(𝑞)|2〉 versus wavenumber 𝑞 
from image analysis of a confocal microscopy time series taken at the midpoint (equator) of 
the GUV. 1000 frames are taken per GUV at 1024x1024 pixel resolution, frame rate and 
pixel size varied on a case by case basis as the maximum magnification that could 
accommodate the whole GUV is used to maximize scan speed and these factors are 
accounted for in the MATLAB analysis software. Fitting 〈|𝑢(𝑞)|2〉 with the equation: 













allows us to quantify the bending rigidity (κ) and tension (𝜎) of individual GUV membranes 
(Pécréaux et al., 2004). The MATLAB program for GUV flicker analysis was kindly provided to 
us by Prof. Pietro Cicuta and co-workers at the University of Cambridge, UK.  Example flicker 





Alex Rautu, S., Orsi, D., Michele, L.D., Rowlands, G., Cicuta, P., S. Turner, M., 2017. The role 
of optical projection in the analysis of membrane fluctuations. Soft Matter 13, 3480–
3483. https://doi.org/10.1039/C7SM00108H 
Bassereau, P., Sorre, B., Lévy, A., 2014. Bending lipid membranes: Experiments after W. 
Helfrich’s model. Adv. Colloid Interface Sci., Special issue in honour of Wolfgang 
Helfrich 208, 47–57. https://doi.org/10.1016/j.cis.2014.02.002 
Currinn, H., Guscott, B., Balklava, Z., Rothnie, A., Wassmer, T., 2016. APP controls the 
formation of PI(3,5)P2 vesicles through its binding of the PIKfyve complex. Cell. Mol. 
Life Sci. 73, 393–408. https://doi.org/10.1007/s00018-015-1993-0 
Pécréaux, J., Döbereiner, H.-G., Prost, J., Joanny, J.-F., Bassereau, P., 2004. Refined contour 
analysis of giant unilamellar vesicles. Eur. Phys. J. E 13, 277–290. 
https://doi.org/10.1140/epje/i2004-10001-9 
Wollert, T., Hurley, J.H., 2010. Molecular mechanism of multivesicular body biogenesis by 
ESCRT complexes. Nature 464, 864–869. https://doi.org/10.1038/nature08849 
Wollert, T., Wunder, C., Lippincott-Schwartz, J., Hurley, J.H., 2009. Membrane scission by 
the ESCRT-III complex. Nature 458, 172–177. https://doi.org/10.1038/nature07836 
Yoon, Y.Z., Hale, J.P., Petrov, P.G., Cicuta, P., 2010. Mechanical properties of ternary lipid 
membranes near a liquid–liquid phase separation boundary. J. Phys. Condens. 
Matter 22, 062101. https://doi.org/10.1088/0953-8984/22/6/062101 
 
 
